newsfilter
← Latest News
GlobeNewswire·

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

BERKELEY HEIGHTS, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases